ArticleDrug design, development and therapy2015

Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis.

Philipp Sievers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.